Family planning considerations in people with multiple sclerosis
KM Krysko, R Dobson, R Alroughani… - The Lancet …, 2023 - thelancet.com
Multiple sclerosis is often diagnosed in patients who are planning on having children.
Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is …
Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is …
Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches
ES Vasileiou, KC Fitzgerald - Current allergy and asthma reports, 2023 - Springer
Abstract Purpose of Review In this review, we provide a comprehensive update on current
scientific advances and emerging therapeutic approaches in the field of multiple sclerosis …
scientific advances and emerging therapeutic approaches in the field of multiple sclerosis …
[HTML][HTML] An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis
IM Dighriri, AA Aldalbahi, F Albeladi, AA Tahiri… - Cureus, 2023 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-inflammatory disease that attacks and damages
myelinated axons in the central nervous system (CNS) and causes nontraumatic …
myelinated axons in the central nervous system (CNS) and causes nontraumatic …
Shared Genetic Risk Factors for Multiple Sclerosis/Psoriasis Suggest Involvement of Interleukin‐17 and Janus Kinase–Signal Transducers and Activators of …
Objective Psoriasis and multiple sclerosis (MS) are complex immune diseases that are
mediated by T cells and share multiple comorbidities. Previous studies have suggested …
mediated by T cells and share multiple comorbidities. Previous studies have suggested …
The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
GS Boles, J Hillert, R Ramanujam… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: The two main phenotypes of multiple sclerosis (MS), primary progressive
(PPMS) and relapsing Onset (ROMS), show clinical and demographic differences …
(PPMS) and relapsing Onset (ROMS), show clinical and demographic differences …
Brain proteome‐wide association study linking‐genes in multiple sclerosis pathogenesis
T Jia, Y Ma, F Qin, F Han… - Annals of Clinical and …, 2023 - Wiley Online Library
Objectives To identify genes that confer MS risk via the alteration of cis‐regulated protein
abundance and verify their aberrant expression in human brain. Methods Utilizing a two …
abundance and verify their aberrant expression in human brain. Methods Utilizing a two …
Sclerosi multipla: epidemiologia
E Leray - EMC-Neurologia, 2023 - Elsevier
La sclerosi multipla (SM) è una malattia neurologica dei giovani adulti (età media all'esordio
intorno ai 30 anni) di cui due terzi dei casi è costituito da donne. Gli studi di prevalenza …
intorno ai 30 anni) di cui due terzi dei casi è costituito da donne. Gli studi di prevalenza …
Monoclonal antibodies in multiple sclerosis treatment
A Moeinafshar, N Rezaei - Translational Neuroimmunology, Volume 8, 2023 - Elsevier
Multiple sclerosis (MS) is one of the common neurological disorders, with approximately 2.5
million confirmed cases worldwide. Its incidence, as a result of predisposal to etiological …
million confirmed cases worldwide. Its incidence, as a result of predisposal to etiological …
Multiple Sclerosis: A Review with a Focus on the Middle East and North Africa Region
M Zeineddine, A Al-Hajje, G Ismail - … of Medical and Health Sciences in …, 2023 - Springer
Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), is the
commonest nontraumatic disabling disease to affect young adults. The incidence of MS is …
commonest nontraumatic disabling disease to affect young adults. The incidence of MS is …
[图书][B] Activity Restrictions, Treatment and Work Disability Among People with Multiple Sclerosis
FS Teni - 2023 - search.proquest.com
Background: Multiple sclerosis (MS) is a disease that commonly occurs among individuals of
working age. Its symptoms are heterogeneous and affect people with MS (PwMS) …
working age. Its symptoms are heterogeneous and affect people with MS (PwMS) …